Equity (Tables)
|
9 Months Ended |
Oct. 31, 2024 |
| Equity [Abstract] |
|
| Schedule of Stock Reserved For Future Issuance |
The Company had shares of common stock reserved for future issuance as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | October 31, 2024 | | January 31, 2024 | | Class A and Class B common stock | | | | | | | | | | | | | Options issued and outstanding | | | 6,617 | | | 8,503 | | | Shares available for issuance under Equity Incentive Plans | | | 29,641 | | | 24,868 | | | RSUs and PSUs issued and outstanding | | | 11,820 | | | 10,930 | | | Shares reserved for issuance to charitable organizations | | | 1,231 | | | 1,404 | | | ESPP | | | 6,722 | | | 5,398 | | | Total | | | 56,031 | | | 51,103 | | | | | | | |
|
| Disclosure of Share-based Compensation Arrangements by Share-based Payment Award |
The awards available for grant under the above Plans for the periods presented were as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | October 31, 2024 | | January 31, 2024 | | Available at beginning of period | | | 24,868 | | | 21,483 | | | Awards authorized | | | 7,878 | | | 7,557 | | | | | | | | | RSUs and PSUs granted | | | (4,743) | | | (6,258) | | | RSUs and PSUs canceled and forfeited | | | 1,530 | | | 1,292 | | | Options canceled and forfeited | | | 108 | | | 777 | | | Options repurchased | | | — | | | 17 | | | Available at end of period | | | 29,641 | | | 24,868 | |
|
| Share-based Payment Arrangement, Option, Activity |
The following table summarizes options activity under the Plans, and related information: | | | | | | | | | | | | | | | | | | | | | | | | | Number of Stock Options Outstanding (in thousands) | | Weighted Average Exercise Price | | Weighted Average Remaining Years | | Aggregate Intrinsic value (in millions) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balances at January 31, 2024 | 8,503 | | | $ | 13.03 | | | 5.85 | | $ | 499.2 | | | Options granted | — | | | — | | | — | | | | | Options exercised | (1,778) | | | 10.07 | | | — | | | | | Options canceled | (11) | | | 13.95 | | | — | | | | | Options forfeited | (97) | | | 18.36 | | | — | | | | Balances at October 31, 2024 | 6,617 | | | $ | 13.66 | | | 5.41 | | $ | 265.3 | | | | | | | | | | Options vested at October 31, 2024 | 5,749 | | | $ | 12.91 | | | 5.25 | | $ | 234.8 | | Options vested and expected to vest at October 31, 2024 | 6,617 | | | $ | 13.66 | | | 5.41 | | $ | 265.3 | |
|
| Schedule of Restricted Stock Units Activity |
The following table summarizes the Company’s RSU activity: | | | | | | | | | | | | | Number of Shares (in thousands) (1) | | Weighted- Average grant date fair value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balances at January 31, 2024 | 7,701 | | | $ | 47.20 | | | Granted | 4,743 | | | 53.38 | | | Vested | (2,323) | | | 49.15 | | | | | | | Canceled/forfeited | (1,530) | | | 49.28 | | Balances at October 31, 2024 | 8,591 | | | $ | 49.69 | |
(1) The table above does not include 3 million RSUs granted to the Company’s founder and the Chief Executive Officer (“CEO”) described below.
|
| Schedule of Share Based Compensation Expense |
The Company recognized stock-based compensation expense as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended October 31, | | Nine Months Ended October 31, | | 2024 | | 2023 | | 2024 | | 2023 | | | | Cost of revenue | $ | 1,993 | | | $ | 1,648 | | | $ | 5,924 | | | $ | 4,760 | | | | | Sales and marketing | 17,012 | | | 16,523 | | | 54,290 | | | 51,582 | | | | | Research and development | 14,384 | | | 12,738 | | | 42,834 | | | 36,917 | | | | | General and administrative | 14,653 | | | 10,425 | | | 36,215 | | | 26,773 | | | | Total stock-based compensation expense (1) | $ | 48,042 | | | $ | 41,334 | | | $ | 139,263 | | | $ | 120,032 | | | |
(1) The table above includes stock-based compensation of JiHu. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
|